CROI, the annual Conference on Retroviruses and Opportunistic Infections (CROI), brings together top scientists, clinicians, and policy makers from around the world to discuss the latest studies and developments in the ongoing battle against HIV/AIDS and related infectious diseases. This year’s meeting is being held in February at the Hynes Convention Center in Boston, Massachusetts. Webcasts, abstracts, electronic posters, and other electronic resources are available online.
Below is a list of talks and posters by researchers associated with the Harvard AIDS Initiative and the Botswana Harvard AIDS Institute Partnership, being presented at this year’s CROI.
Tuesday, February 23, 2016
SESSION 0-3 Oral Abstracts
11:00am Room 304/306
Prevention and Treatment of Pediatric HIV Infections
Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children
Roger L. Shapiro; Michael Hughes; Kathleen Powis; Gbolahan Ajibola; Kara Bennett; Sikhulile Moyo; Joseph Makhema; Sheryl Zwerski; M. Essex; Shahin Lockman
SESSION TD-2 Themed Discussion
1:45am –2:45pm Room 312
Global Burden and Mortality of Cancer in HIV
Themed Discussion Leader William A. Blattner, Institute of Human Virology, Baltimore, MD, USA
Cancer Versus Tuberculosis Mortality Among HIV-Infected Individuals in Botswana
Scott Dryden-Peterson; Gita Suneja; Heluf Medhin; Memory Bvochora-Nsingo; Mukendi K. Kayembe; Neo Tapela; Shahin Lockman
SESSION P-E1 Poster Abstracts
2:45pm-4:00pm Hall A/B
Antibody Responses to HIV Infection: What Drives Them and How They Affect the Virus
Humoral Immune Pressure Selects for HIV-1 CXCR4- Using Variants
Nina Lin; Oscar Gonzalez; Carlos Becerril; Behzad Etemad; Hong Lu; Xueling Wu; Shahin Lockman; M. Essex; Daniel Kuritzkes; Manish Sagar
SESSION P-S4 Poster Abstracts
2:45pm-4:00pm Hall D
MTCT: Regimens, Rates, and Early Infant Diagnosis
Infant Cotrimoxazole Prophylaxis Associated With Commensal Bacterial Resistance
Kathleen Powis; Sajini Souda; Shahin Lockman; Gbolahan Ajibola; Kara Bennett; Florence Chilisa; Michael Hughes; Sikhulile Moyo; Joseph Makhema; Roger L. Shapiro
HIV-Exposed Children Account for More Than Half of 24-Month Mortality in Botswana
Rebecca Zash; Jean Leidner; Sajini Souda; Kelebogile Binda; Heather J. Ribaudo; Sikhulile Moyo; Kathleen Powis; Joseph Makhema; Shahin Lockman; Roger L. Shapiro
Maternal ART and Hospitalization or Death Among HIV-Exposed Uninfected Infants
Scott Dryden-Peterson; Tatiana Ramos; Roger L. Shapiro; Shahin Lockman
SESSION P-T1 Poster Abstracts
2:45pm-4:00pm Hall D
Pharmacokinetics: Efficacy and Safety of New ARVs in Children
Nevirapine (NVP) Concentrations in HIV-Infected Newborns Receiving Therapeutic Dosing
Edmund Capparelli; Kenneth Maswabi; Steven Rossi; Muchaneta Bhondai; Sikhulile Moyo; Patrick Jean-Philippe; Michael Hughes; Mathias Lichterfeld; Daniel Kuritzkes; Roger L. Shapiro
SESSION P-W1 Poster Abstracts
2:45pm-4:00pm Hall D
Populations at Risk for HIV
Young HIV+ Adults in Botswana Less Likely to Seek Treatment or Be Virally Suppressed
Vladimir Novitsky; Tendani Gaolathe; Mompati Mmalane; Sikhulile Moyo; Molly Pretorius Holme; Kathleen Powis; Kathleen Wirth; Eric Tchetgen Tchetgen; Shahin Lockman; M. Essex
Wednesday, February 24, 2016
SESSION O-10 Oral Abstracts
10:00am Ballroom A
Getting to 90-90-90
Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage
Tendani Gaolathe; Kathleen Wirth; Molly Pretorius Holme; Joseph Makhema; Sikhulile Moyo; Eric Tchetgen Tchetgen; Refeletswe Lebelonyane; Lisa A. Mills; M. Essex; Shahin Lockman
SESSION TD-10 Themed Discussion
1:45am –2:45pm Room 311
New Drugs for Kids: What’s Taking so Long?
Themed Discussion Leader Martina Penazzato, World Health Organization, Geneva, Switzerland
Nevirapine (NVP) Concentrations in HIV-Infected Newborns Receiving Therapeutic Dosing
Edmund Capparelli; Kenneth Maswabi; Steven Rossi; Muchaneta Bhondai; Sikhulile Moyo; Patrick Jean-Philippe; Michael Hughes; Mathias Lichterfeld; Daniel Kuritzkes; Roger L. Shapiro
SESSION P-O1 Poster Abstracts
2:45pm-4:00pm Hall A/B
Global Burden and Mortality of Cancer in HIV
Cancer Versus Tuberculosis Mortality Among HIV-Infected Individuals in Botswana
Scott Dryden-Peterson; Gita Suneja; Heluf Medhin; Memory Bvochora-Nsingo; Mukendi K. Kayembe; Neo Tapela ; Shahin Lockman
SESSION P-O2 Poster Abstracts
2:45pm-4:00pm Hall A/B
Anal and Cervical Cancer: Treatment and Prevention
HPV Type Distribution in HIV-Infected Persons With Anal HSIL and Impact on Recurrence
Michael Gaisa; Keith M. Sigel; Stephen Goldstone; Matthew Silverstein; Iain MacLeod
SESSION P-S5 Poster Abstracts
2:45pm-4:00pm Hall D
Mind the Gaps: Optimizing the PMTCT Cascade
Optimizing PMTCT Outcomes in Rural North-Central Nigeria: A Cluster-Randomized Study
Muktar H. Aliyu; Meridith Blevins; Carolyn M. Audet; Marcia Kalish; Mary Lou Lindegren; Usman I. Gebi; Obinna Onwujekwe; Bryan E. Shepherd; C. William Wester; Sten H. Vermund
SESSION P-S7 Poster Abstracts
2:45pm-4:00pm Hall D
Birth Outcomes and Mortality in HIV- and ARV-Exposed Infants
Higher Mortality in HIV-Exposed/Uninfected vs HIV-Unexposed Infants, Botswana
Gbolahan Ajibola; Gloria Mayondi; Jean Leidner; Haruna Jibril; Joseph Makhema; Mompati Mmalane; Modiegi Diseko; Roger L. Shapiro; Betsy Kammerer; Shahin Lockman
SESSION P-X3 Poster Abstracts
2:45pm-4:00pm Hall D
HIV Testing and Prevention
Cross-Sectional HIV Incidence at Scale-up of ART in 24 Rural Communities in Botswana
Sikhulile Moyo; Coretah Boleo; Terence Mohammed; Lucy Mupfumi; Simani Gaseitsiwe; Rosemary Musonda; Erik van Widenfelt; Joseph Makhema; M. Essex; Vladimir Novitsky
Thursday, February 25, 2016
SESSION TD-14 Themed Discussion
1:45am –2:45pm Room 302
Mind the Gaps: Optimizing the PMTCT Cascade
Themed Discussion Leader Marcel Yotebieng, Ohio State University, Columbus, OH, US
Optimizing PMTCT Outcomes in Rural North-Central Nigeria: A Cluster-Randomized Study
Muktar H. Aliyu; Meridith Blevins; Carolyn M. Audet; Marcia Kalish; Mary Lou Lindegren; Usman I. Gebi; Obinna Onwujekwe; Bryan E. Shepherd; C. William Wester; Sten H. Vermund
SESSION P-G5 Poster Abstracts
2:45pm-4:00pm Hall A/B
Clinical Distinctions and Therapeutic Response
Statin or ACE/ARB Effects on Neurocognitive Function of HIV-Infected Adults
Kristine M. Erlandson; Douglas Kitch; C. William Wester; Robert Kalayjian; Edgar T. Overton; Jose R. Castillo-Mancilla; Susan L. Koletar; Constance A. Benson; Kevin R. Robertson; Judith Lok
SESSION P-S9 Poster Abstracts
2:45pm-4:00pm Hall D
Outcomes of HIV and ARV-Exposed Infants, Children, and Youth
Similar HIV Protection From ZDV vs NVP Prophylaxis in Formula-Fed Infants in Botswana
Kathleen Powis; Shahin Lockman; Gbolahan Ajibola; Kara Bennett; Jean Leidner; Michael Hughes; Sikhulile Moyo; Erik van Widenfelt; Joseph Makhema; Roger L. Shapiro
SESSION P-X7 Poster Abstracts
2:45pm-4:00pm Hall D
Access, ART Initiation, Retention, and Outcomes in the Global South
Imputing Clinical Records From Routine Laboratory Data: Date of ART Initiation
Mhairi Maskew; Jacob Bor; Cheryl J. Hendrickson; William B. MacLeod; Till Bärnighausen; Deenan Pillay; Ian M. Sanne; Sergio Carmona; Wendy Stevens; Matthew P. Fox
SESSION P-X8 Poster Abstracts
2:45pm-4:00pm Hall D
Viral Suppression
Measuring Viral Load Suppression in South Africa Using a Novel, National Database
William B. MacLeod; Jacob Bor; Nicole Fraser; Zara Shubber; Ian M. Sanne; Wendy Stevens; Tshepo Molapo; Mokgadi Phokojoe; Yogan Pillay; Sergio Carmona